A systematic review of Federal Drug Administration Docket for community consultation and public disclosure in exception from informed consent trials
- 17 October 2017
- journal article
- review article
- Published by SAGE Publications in Clinical Trials
- Vol. 15 (1) , 29-35
Abstract
Background: Exception from informed consent imposes community consultation and public disclosure requirements on clinical investigation in critically ill and injured patients. In 2011, the Food and Drug Administration instructed sponsors to submit publically disclosed information to the Food and Drug Administration Docket, but to date there has been no comprehensive analysis of available data. We summarized the community consultation and public disclosure practices of exception from informed consent trials published on the Food and Drug Administration Docket in order to better understand the breadth of common practices that exists among acute care clinical research. Methods: We performed quantitative and qualitative analysis of Docket FDA-1995-S-0036 from its initiation until June 2017 in order to summarize existing practices. We developed a 4-point scoring system to categorize public disclosure and community consultation based on inclusion of key components such as a detailed plan, schedule of events conducted, results, and materials uploaded. Results: The 177 docket submissions represented 34 trials. Material related to public disclosure accounted for 49% of pages, community consultation 45%, and 6% other. The median Docket Review Content Score for public disclosure was 3 (mean: 2.5, range: 0–4) and 2 (mean: 2.1, range: 0–4) for community consultation materials. Conclusion: The public information contained in the Docket varies broadly by trial and content. Additionally, as evidenced by the wide range of the Docket Review Content Score, submission guidelines are not followed uniformly. Given the apparent uncertainty about what should be submitted, and the need for best practice recommendations, it is valuable to categorize and summarize existing community consultation and public disclosure content.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (5 U01 NS056975 08)
This publication has 11 references indexed in Scilit:
- Variation of community consultation and public disclosure for a pediatric multi-centered “Exception from Informed Consent” trialClinical Trials, 2014
- Social Media and Community Engagement in Trials Using Exception From Informed ConsentCirculation, 2013
- The Random Dialing Survey as a Tool for Community Consultation for Research Involving the Emergency Medicine Exception From Informed ConsentAnnals of Emergency Medicine, 2009
- The Research on Community Consultation: An Annotated BibliographyAcademic Emergency Medicine, 2007
- The Research on Community Consultation: An Annotated BibliographyAcademic Emergency Medicine, 2007
- Struggling with the Rule: The Exception from Informed Consent in Resuscitation ResearchAcademic Emergency Medicine, 2007
- Communicating with Communities about Emergency ResearchAcademic Emergency Medicine, 2005
- Communicating with Communities about Emergency ResearchAcademic Emergency Medicine, 2005
- Protecting research subjects under the waiver of informed consent for emergency research: Experiences with efforts to inform the communityAnnals of Emergency Medicine, 2003
- The Role of Institutional Support in Protecting Human Research SubjectsAcademic Medicine, 2000